Vivo Mobile Communication Co., Ltd.

Guangzhou Medical University

Shenzhen Ousen Technology Co., Ltd

Wei Yi

Zhi Zhou

Du Feng

Yongquan Hu

Haixia Zhuang

Junyuan Tang

The present application relates to the field of communications technologies, and provides a method for controlling a radio frequency front-end device and user equipment, where the user equipment includes a processor and the radio frequency front-end device, and the method includes: receiving, by the radio frequency front-end device, a switch control instruction from the processor, where the switch control instruction is an instruction sent by the processor to the radio frequency front-end device at a first moment; and performing, by the radio frequency front-end device, on-off switching in response to the switch control instruction.

Method for controlling radio frequency front-end device and user equipment

Disclosed is a wide-jaw-opening nail clipper, and the nail clipper includes: a first blade head portion formed at a first handle, and an upper blade formed at the first blade head portion, where an upper blade tip extends forward farther than an upper blade tail; a second blade head portion formed at a second handle, where the second blade head portion is provided with a butt-joint position, a lower blade is formed at the second blade head portion, a lower blade tip extends forward farther than a lower blade tail, and the upper blade tip and the lower blade tip both form a pointed cone shape; and the first blade head portion is rotatably connected to the second blade head portion, an elastic member is installed inside a mounting groove, and the first blade head portion and the second blade head portion together form a trimming blade head.

Wide-jaw-opening nail clipper

The present application belongs to the technical field of proteolysis-targeting chimeras (PROTACs), and discloses a PROTAC molecule and a preparation method and use thereof. A ligand for a target protein in the PROTAC molecule of the present application is a pyridine carboxylic acid-1-oxide derivative. In cell and zebrafish experiments, the PROTAC molecule exhibits no toxic and side effects at a drug concentration allowing a desired effect. At a cellular level, an inhibition level of the PROTAC molecule for human tyrosinase (TYR) reaches less than or equal to 1 μmol/L. The PROTAC molecule in the present application can significantly reduce the generation of melanin by degrading TYR, and has excellent solubility, safety, and efficacy and a low effective concentration.

Proteolysis-targeting chimera molecule and preparation method and use thereof

Gun magnet mounting device

Growing community of inventors

Guangdong, China

Wei Yi